Angiotensinamide
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2-[(1-{2-[2-(2-{2-[2-(2-amino-3-carbamoylpropanamido)-5-[(diaminomethylidene)amino]pentanamido]-3-methylbutanamido}-3-(4-hydroxyphenyl)propanamido)-3-methylbutanamido]-3-(1H-imidazol-5-yl)propanoyl}pyrrolidin-2-yl)formamido]-3-phenylpropanoic acid | |
| Clinical data | |
| Routes of administration | Intravenous infusion |
| Identifiers | |
| CAS Number |
53-73-6 |
| ATC code | C01CX06 (WHO) |
| PubChem | CID 10351092 |
| ChemSpider |
8526544 |
| UNII |
7WAL1X78KV |
| KEGG |
D02939 |
| ChEMBL | CHEMBL409803 |
| Chemical data | |
| Formula | C49H70N14O11 |
| Molar mass | 1031.17 g/mol |
| |
| |
| (verify) | |
Angiotensinamide (INN; BAN and USAN angiotensin amide) is a potent vasoconstrictor used as a cardiac stimulant. It is a derivative of angiotensin II.
See also
| ||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
